Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
May 12, 2022May 16, 2022Hoberman Kenneth
Dir
BuyNuvectis Pharma, Inc.NVCT$17.4$104,400+9.81%
Mar 09, 2020Mar 14, 2020Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$4.97$130,211-3.28%
Feb 25, 2020Feb 29, 2020Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$6.42$74,132-1.43%
Jan 22, 2020Jan 25, 2020Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$7.02$155,416-3.55%
Jan 08, 2020Jan 11, 2020Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$10.37$137,174-2.08%
Dec 23, 2019Jan 03, 2020Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$10.84$501,959-6.78%
Jun 24, 2019Jun 28, 2019Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$15.07$710,096-6.46%
May 14, 2019May 18, 2019Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$14.27$368,409-3.42%
Mar 11, 2019Mar 16, 2019Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$11.11$289,702-3.34%
Mar 07, 2019Mar 09, 2019Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$11.36$34,023-0.38%
Feb 25, 2019Feb 28, 2019Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$12.05$127,212-1.33%
Jan 08, 2019Jan 12, 2019Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$10.15$137,502-2.05%
Nov 26, 2018Dec 01, 2018Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$11.85$311,608-3.83%
Mar 12, 2018Mar 15, 2018Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$17.14$514,085-6.82%
Mar 07, 2018Mar 10, 2018Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$16.55$50,097-0.68%
Feb 26, 2018Mar 01, 2018Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$17.43$192,164-2.88%
Feb 15, 2018Feb 17, 2018Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$15.67$29,005-0.48%
Jan 08, 2018Jan 13, 2018Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$13.93$195,577-3.52%
Dec 15, 2017Dec 20, 2017Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$14.18$169,942-2.92%
Mar 07, 2017Mar 10, 2017Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$8.16$19,111-0.57%
Feb 27, 2017Mar 02, 2017Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$6.99$56,109-2.79%
Feb 16, 2017Feb 18, 2017Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$6.42$9,681-0.52%
Jan 10, 2017Jan 14, 2017Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$13.82$125,900-3.05%
Mar 08, 2016Mar 11, 2016Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$5.34$12,880-0.80%
Feb 17, 2016Feb 20, 2016Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$4.54$6,824-0.71%
Mar 19, 2015Mar 20, 2015Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$16.43$284,354-12.41%
Feb 18, 2015Feb 20, 2015Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$14.02$22,334-1.78%
Sep 02, 2014Sep 03, 2014Hoberman Kenneth
COO
BuyStemline Therapeutics IncSTML$10.99$21,975+2.18%
May 21, 2014May 23, 2014Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$13.32$203,130-14.84%
Nov 22, 2013Nov 28, 2013Hoberman Kenneth
COO
SellStemline Therapeutics IncSTML$20.72$920,618-33.60%